Makiz

Makiz is a pharmaceutical company primarily focused on the development, manufacturing, and commercialization of specialized therapies for rare diseases and metabolic disorders. The company operates with a strong presence in the Latin American market, particularly in Mexico, where it provides access to high-complexity medications. Makiz emphasizes a patient-centric approach, working to bridge the gap between innovative therapeutic developments and patients with unmet medical needs in underserved regions. Their portfolio includes a range of products aimed at improving the quality of life for individuals suffering from chronic and debilitating conditions.